Keyphrases
Cell-based
100%
Gene Therapy
100%
Market Access
100%
Market Authorization
100%
Health Technology Assessment
62%
Medicinal Products
25%
Product Quality
25%
Development Technology
25%
Regulatory Technology
25%
Technology Assessment Framework
25%
Clinical Development
12%
Patient Access
12%
Chronic Disease
12%
Systems Perspective
12%
High Risk
12%
High Burden
12%
Cost-effectiveness
12%
Quality Assurance
12%
Risk Cost
12%
Early Development
12%
Reimbursement
12%
Novel Genes
12%
Marketing Authorization
12%
Target Price
12%
Access Issues
12%
Innovative Therapies
12%
Product Manufacturing
12%
Quality Safety
12%
Curative Effect
12%
Payers
12%
Product Characteristics
12%
Development Cost
12%
Downstream Process Development
12%
Budget Impact
12%
Product Safety
12%
Product Efficacy
12%
New Mechanisms of Action
12%
Product Experience
12%
Therapy Development
12%
Biomedical Innovation
12%
Capability Building
12%
Translational Challenges
12%
Product Handling
12%
Disease Burden
12%
Developer's Perspective
12%
Medicine and Dentistry
Cell Therapy
100%
Health Technology
50%
Technology Assessment
50%
Health Care Cost
25%
Chronic Disease
12%
Cost-Effectiveness Analysis
12%
Assessment in Health Technology
12%
Experimental Therapy
12%
Therapy Development
12%
Pharmacology, Toxicology and Pharmaceutical Science